Apyx Medical (APYX)

Apyx Medical on one page: short interest, daily short volume, fails to deliver, large holders, 13F holders, earnings dates and insider trades. Listed on Nasdaq.

Download CSV

214K

Short interest

settlement 2026-10-15

1.8

Days to cover

+0.6 days vs prior

42.8%

Short share of volume

2026-11-02

1,189

Fails to deliver

settlement 2026-10-09

Thu 5 Nov

Next earnings

estimated date

Insider flow, 90 days

0 buys, 0 sells

As of 2026-11-02.

Short interest

FINRA, twice a month. The newest 48 settlements in the table, 48 in the chart. JSON

As of 15 October 2026, short interest in APYX is 213,730 shares, down 4,319 shares over the last month. Over the last 48 readings it ranged from 109,325 shares (15 December 2025) to 413,602 shares (15 May 2025). At the reported average volume of 119K shares a day that is 1.8 days to cover.

Embed this chart.The embed keeps its attribution line.

<iframe src="https://xoomar.com/embed/stocks/apyx" width="100%" height="440" style="border:0;max-width:100%" loading="lazy" title="XOOMAR chart"></iframe>

Preview Dark previewAdd ?theme=dark to the src for a dark chart.

Settlement	Shares short	Change	Avg daily volume	Days to cover
2026-10-15	213,730	+3.3%	118,915	1.80
2026-09-30	206,825	-5.2%	176,560	1.17
2026-09-15	218,049	+6.3%	88,493	2.46
2026-08-31	205,197	-10.9%	160,814	1.28
2026-08-14	230,354	-13.8%	154,243	1.49
2026-07-31	267,145	+6.2%	56,950	4.69
2026-07-15	251,668	+42.0%	64,814	3.88
2026-06-30	177,278	+26.9%	147,473	1.20
2026-06-15	139,664	-34.1%	200,016	1.00
2026-05-29	211,948	+26.6%	115,623	1.83
2026-05-15	167,446	-24.3%	351,036	1.00
2026-04-30	221,167	+12.9%	110,327	2.00
2026-04-15	195,810	+1.6%	119,763	1.63
2026-03-31	192,757	+16.9%	134,319	1.44
2026-03-13	164,872	-5.0%	166,030	1.00
2026-02-27	173,573	+22.3%	64,528	2.69
2026-02-13	141,982	+11.8%	157,565	1.00
2026-01-30	127,033	+13.5%	137,870	1.00
2026-01-15	111,929	+0.2%	124,531	1.00
2025-12-31	111,685	+2.2%	52,515	2.13
2025-12-15	109,325	-4.1%	63,876	1.71
2025-11-28	113,947	-59.3%	176,614	1.00
2025-11-14	279,717	-22.9%	168,646	1.66
2025-10-31	362,649	+16.0%	58,724	6.18
2025-10-15	312,749	+20.2%	205,631	1.52
2025-09-30	260,226	+10.5%	68,668	3.79
2025-09-15	235,408	+1.5%	54,179	4.35
2025-08-29	231,895	-25.9%	64,265	3.61
2025-08-15	313,172	-2.0%	93,536	3.35
2025-07-31	319,516	+6.8%	105,090	3.04
2025-07-15	299,211	+44.4%	124,866	2.40
2025-06-30	207,251	-2.7%	90,124	2.30
2025-06-13	212,930	-28.9%	53,605	3.97
2025-05-30	299,311	-27.6%	66,864	4.48
2025-05-15	413,602	+59.8%	774,235	1.00
2025-04-30	258,778	+4.7%	69,151	3.74
2025-04-15	247,289	+71.0%	72,419	3.41
2025-03-31	144,625	+15.4%	44,138	3.28
2025-03-14	125,316	-9.8%	54,240	2.31
2025-02-28	138,999	-2.0%	26,024	5.34
2025-02-14	141,853	-4.9%	16,469	8.61
2025-01-31	149,225	+0.4%	21,196	7.04
2025-01-15	148,570	+17.6%	50,496	2.94
2024-12-31	126,370	+1.8%	64,152	1.97
2024-12-13	124,186	+3.5%	73,201	1.70
2024-11-29	119,969	-14.6%	54,258	2.21
2024-11-15	140,478	-39.0%	77,728	1.81
2024-10-31	230,246	-2.0%	38,585	5.97

Daily short volume

FINRA Reg SHO, the last 30 sessions. JSON

As of 2 November 2026, the short share of APYX volume is 42.8%, up 16.1 points over the last five sessions. Over the last 30 readings it ranged from 6.6% (20 October 2026) to 64.8% (28 October 2026). The latest reading is 12.5 points above the 30-session average of 30.3%, on 68K shares reported.

Date	Short volume	Total volume	Short share	Exempt
2026-11-02	29K	68K	42.8%	0
2026-10-30	4K	14K	28.6%	0
2026-10-29	11K	29K	36.8%	0
2026-10-28	10K	16K	64.8%	0
2026-10-27	6K	29K	19.7%	0
2026-10-26	24K	89K	26.6%	0
2026-10-23	16K	51K	31.3%	0
2026-10-22	32K	84K	38.0%	0
2026-10-21	12K	26K	46.9%	0
2026-10-20	10K	153K	6.6%	1,230
2026-10-19	22K	62K	35.5%	0
2026-10-16	4K	13K	33.4%	0
2026-10-15	12K	112K	10.4%	0
2026-10-14	3K	18K	17.3%	0
2026-10-13	14K	52K	26.7%	0
2026-10-12	4K	33K	13.2%	0
2026-10-09	14K	65K	21.0%	0
2026-10-08	23K	56K	40.2%	0
2026-10-07	6K	16K	35.9%	0
2026-10-06	7K	68K	10.5%	0
2026-10-05	4K	17K	24.8%	0
2026-10-02	9K	16K	58.0%	0
2026-10-01	28K	185K	15.1%	0
2026-09-30	29K	239K	12.2%	300
2026-09-29	75K	217K	34.3%	8,815
2026-09-28	60K	167K	35.7%	7,035
2026-09-25	12K	71K	17.3%	300
2026-09-24	14K	27K	51.0%	0
2026-09-23	10K	35K	27.1%	0
2026-09-22	18K	39K	47.2%	400

Fails to deliver

SEC, the last 30 settlement dates with a fail. JSON

As of 9 October 2026, the fails-to-deliver balance in APYX is 1,189 shares, down 32,723 shares over the last settlement date. Over the last 30 readings it ranged from 1 share (18 May 2026) to 58,000 shares (15 October 2025). The latest reading sits at the bottom of that range.

Settlement	Shares failed	Price	Value
2026-10-09	1,189	$2.36	$3K
2026-06-30	33,912	$4.69	$159K
2026-06-08	1,835	$4.47	$8K
2026-05-28	2,424	$3.90	$9K
2026-05-27	2,424	$4.09	$10K
2026-05-26	2,424	$4.13	$10K
2026-05-18	1	$4.05	$4
2026-04-09	4,173	$3.81	$16K
2026-03-31	53	$3.58	$190
2026-02-18	31,611	$3.84	$121K
2026-02-05	64	$3.97	$254
2026-01-20	469	$3.99	$2K
2025-12-05	1,455	$4.03	$6K
2025-12-01	699	$4.01	$3K
2025-11-28	999	$4.01	$4K
2025-11-26	999	$4.00	$4K
2025-11-13	44	$4.33	$191
2025-10-29	5,810	$3.10	$18K
2025-10-28	6,523	$3.13	$20K
2025-10-27	6,253	$3.21	$20K
2025-10-23	87	$3.03	$264
2025-10-22	188	$3.08	$579
2025-10-17	54,160	$3.11	$168K
2025-10-16	58,000	$3.11	$180K
2025-10-15	58,000	$3.40	$197K
2025-10-14	6,458	$3.00	$19K
2025-10-10	43,646	$2.99	$131K
2025-10-09	32,516	$2.87	$93K
2025-10-08	15,008	$2.84	$43K
2025-10-07	12,725	$2.89	$37K

Insider trades

SEC Form 4, newest first. JSON

No open-market insider trades were reported for APYX in the last 90 days. The most recent filings are listed below. Latest filing: Waldman Lawrence (Director) on 2026-06-30.

Date	Insider	Title	Type	Shares	Price	Value	Owned after
2026-06-30	Waldman Lawrence	Director	Tax withholding	5K	$4.49	$23K	12K
2026-06-30	Waldman Lawrence	Director	Exercise or conversion	12K	$1.88	$23K	17K
2026-06-15	Roman Shawn David	Chief Operating Officer	Tax withholding	11K	$4.60	$48K	16K
2026-06-15	Roman Shawn David	Chief Operating Officer	Exercise or conversion	15K	$3.23	$48K	15K
2026-06-11	Vizirgianakis Stavros G.	Director	Grant	450K	$0.00	$0	2.2M
2026-03-15	CITRONOWICZ MOSHE	Senior Vice President	Exercise or conversion	37K	$1.80	$67K	494K
2026-01-27	Roman Shawn David	Chief Operating Officer	Exercise or conversion	12K	$1.80	$22K	12K
2024-08-13	HILL MATTHEW C	Chief Financial Officer	Buy	6K	$1.13	$7K	9K
2024-08-13	HILL MATTHEW C	Chief Financial Officer	Buy	5K	$1.13	$6K	8K
2023-12-12	HILL MATTHEW C	Chief Financial Officer	Buy	3K	$2.19	$5K	3K
2023-11-14	Goodwin Charles D. II	Chief Executive Officer	Buy	50K	$1.57	$79K	90K
2023-07-12	Waldman Lawrence	Director	Exercise or conversion	5K	$2.97	$16K	5K
2023-06-26	Hornsby Todd	Executive Vice President	Sell	15K	$7.56	$113K	40
2023-06-26	Hornsby Todd	Executive Vice President	Exercise or conversion	15K	$1.77	$27K	15K
2023-06-26	Hornsby Todd	Executive Vice President	Sell	15K	$7.56	$113K	0
2023-06-06	Geraghty Michael	Director	Exercise or conversion	10K	$2.79	$28K	28K
2022-08-29	Goodwin Charles D. II	Chief Executive Officer	Buy	2K	$5.93	$12K	30K
2022-08-29	Goodwin Charles D. II	Chief Executive Officer	Buy	10K	$5.97	$58K	40K
2022-07-11	Waldman Lawrence	Director	Exercise or conversion	24K	$2.54	$61K	38K
2022-07-11	CITRONOWICZ MOSHE	Sr. V.P. of Operations	Exercise or conversion	30K	$2.54	$76K	457K
2022-07-06	Geraghty Michael	Director	Exercise or conversion	4K	$2.54	$10K	18K
2022-07-05	MAKRIDES ANDREW	Director	Tax withholding	14K	$6.14	$83K	624K
2022-07-05	MAKRIDES ANDREW	Director	Exercise or conversion	30K	$2.54	$76K	638K
2022-05-19	Waldman Lawrence	Director	Exercise or conversion	8K	$2.79	$22K	14K
2022-05-11	Geraghty Michael	Director	Exercise or conversion	6K	$2.79	$17K	14K
2022-03-21	Swandal Craig A.	Director	Exercise or conversion	17K	$4.98	$85K	17K
2022-01-07	Swandal Craig A.	Director	Exercise or conversion	7K	$9.42	$68K	60K
2021-03-08	Waldman Lawrence	Director	Exercise or conversion	6K	$2.81	$16K	6K
2021-03-05	Geraghty Michael	Director	Exercise or conversion	8K	$2.81	$21K	8K
2020-05-13	Goodwin Charles D. II	Chief Executive Officer	Buy	28K	$3.30	$93K	28K
2019-10-01	Swandal Craig A.	Director	Exercise (in or at the money)	10K	$5.30	$53K	36K
2019-04-04	Swandal Craig A.	Director	Exercise (out of the money)	6K	$5.30	$32K	26K
2019-04-04	Swandal Craig A.	Director	Exercise (in or at the money)	2K	$2.37	$5K	20K
2019-01-10	Swandal Craig A.	Director	Exercise (in or at the money)	10K	$2.37	$24K	10K
2019-01-10	Swandal Craig A.	Director	Exercise (in or at the money)	8K	$5.30	$42K	18K

Form 4 filings are due within two business days of the trade. Insiders sell for many reasons that say nothing about the company; open-market buys are rarer.

Large holders (13D and 13G)

One row per reporting person with its latest filing, newest first. JSON

6 holders report 5% or more of APYX in their latest filing, all on Schedule 13G (passive). The largest reported stake is Nantahala Capital Management, LLC at 10.0% of the class (4,112,705 shares), filed 2026-02-13 for an event on 2025-12-31.

Filed	Form	Holder	Shares	Of class	Event
2026-10-28	13G	Kanen Davidindividual	2.3M	5.4%	2026-10-21
2026-10-28	13G	Kanen Wealth Management LLCinvestment adviser	2.3M	5.4%	2026-10-21
2026-10-28	13G	Philotimo Fund, LPpartnership	1.4M	3.4%	2026-10-21
2026-10-28	13G	Philotimo Focused Growth & Income Fundother entity	855K	2.0%	2026-10-21
2026-07-21	13G/Ano. 4	ROYCE & ASSOCIATES LPinvestment adviser	3.3M	7.8%	2026-06-30
2026-02-13	13G/Ano. 1	Nantahala Capital Management, LLCinvestment adviser	4.1M	10.0%	2025-12-31
2026-02-13	13G/Ano. 1	Wilmot B. Harkeyparent holding company	4.1M	10.0%	2025-12-31
2026-02-13	13G/Ano. 1	Daniel Mackparent holding company	4.1M	10.0%	2025-12-31

13F holders

Tracked managers holding APYX at their latest 13F. JSON

4 of the 30 tracked managers held APYX at their latest 13F, $4.5M in total at quarter-end prices. Renaissance Technologies is the largest at $2.5M (0.0% of its portfolio) as of 2026-06-30. Over the prior quarter 2 added shares and 2 cut.

Fund	Quarter	Shares	Value	Of portfolio	Change in shares
Renaissance Technologies	2026-06-30	554K	$2.5M	0.00%	+252K
Millennium Management	2026-06-30	243K	$1.1M	0.00%	-19K
Citadel Advisors	2026-06-30	168K	$756K	0.00%	+61K
Point72 Asset Management	2026-06-30	26K	$118K	0.00%	-8K

Only the 30 tracked managers on the funds hub; a 13F reports long positions in US listed stock at quarter end, 45 days late, and says nothing about shorts or positions sold since.

What this page is

Apyx Medical in the regulatory record

Regulators publish company data in separate files that never sit next to each other: FINRA's twice-monthly short interest, its daily short sale volume, the SEC's fails-to-deliver counts, and each insider's Form 4. A company page puts those series for one ticker on one URL, with planned sales, large holders, 13F holders and financials beside them, so the short position, the daily flow, the settlement fails and what insiders are doing can be read together.

Each section has its own history table, a one-line summary of the latest figures and its own JSON and CSV links, and says when its source last updated.

This page follows Apyx Medical (APYX), SEC CIK 719135, listed on Nasdaq. The cross-market tables live on the short interest and insider transactions hubs.

Source and updates

Short interest: FINRA consolidated short interestSource: FINRA.Twice a month, about eight business days after settlement. Latest 2026-10-15.JSON and CSV
Daily short volume: FINRA Reg SHO daily filesSource: FINRA.Every trading day, the morning after FINRA posts it. Latest 2026-11-02.JSON and CSV
Fails to deliver: SEC fails-to-deliver dataSource: SEC.Twice a month, a few weeks after the half month ends. Latest 2026-10-09.JSON and CSV
Large holders: SEC EDGAR Schedule 13D and 13GSource: SEC.New filings appear shortly after the SEC posts them. A 13D is due within five business days of crossing 5%; a 13G follows the passive schedule. Latest 2026-10-28.JSON and CSV
13F holders: SEC EDGAR Form 13F-HRSource: SEC.Quarterly, filed within 45 days of quarter end; 30 tracked managers. Latest 2026-06-30.JSON and CSV
Earnings dates: SEC EDGAR 8-K filings (Item 2.02)Source: SEC.Twice a day. Reported dates come from the company's 8-K filings; the next date is marked as an estimate until the 8-K arrives. Latest 2026-08-06.JSON and CSV
Insider trades: SEC EDGAR Form 4Source: SEC.New filings appear shortly after the SEC posts them; they're due two business days after the trade. Latest 2026-06-30.JSON and CSV
Company record: EDGAR filing index for CIK 719135Ticker, name and exchange from the SEC's company list, refreshed weekly.
Rate limits: 10 requests a minute without a key, 30 with a free key from a free account.

How to read it

Read the position against the flow: rising short interest with a high daily short share is new shorting; rising short interest with a normal short share is old shorts holding on.
Insider buys next to a large short position are rare and stand out; insider sells next to one are common and mean little.
Fails to deliver matter relative to the float, not in absolute shares; a million failed shares in a mega cap is noise.

Analysis of what the data shows, not advice. XOOMAR does not recommend buying, selling or holding anything.

Datasets

Frequently Asked Questions

How much of APYX is sold short?

213,730 shares were held short at the 2026-10-15 settlement, 1.8 days of average volume. FINRA publishes the next count about eight business days after the 15th and the last business day of the month.

What is APYX's daily short volume?

On 2026-11-02, 29,145 of the 68,182 APYX shares reported to FINRA were sold short, 42.8% of the day's reported volume. Short volume is a flow for one day, not a position.

Does APYX have fails to deliver?

The SEC's latest file shows 1,189 APYX shares failed to deliver at settlement 2026-10-09. Fails are reported per settlement date and published twice a month with a lag.

Are APYX insiders buying or selling?

No open-market insider trades were reported for APYX in the last 90 days. The most recent filings are listed below. Latest filing: Waldman Lawrence (Director) on 2026-06-30.

Who owns 5% or more of APYX?

Which tracked 13F managers own APYX?

4 of the 30 tracked 13F managers held APYX shares at their latest filing, $4.5M in all. The largest: Renaissance Technologies (554K shares, $2.5M), Izzy Englander's Millennium Management (243K shares, $1.1M), Ken Griffin's Citadel Advisors (168K shares, $756K), Steve Cohen's Point72 Asset Management (26K shares, $118K).

Data on this page is provided for informational purposes only and is not financial advice. See our editorial policy.

Apyx Medical (APYX)

Short interest

Daily short volume

Fails to deliver

Insider trades

Large holders (13D and 13G)

13F holders

Apyx Medical in the regulatory record

Source and updates

How to read it

Other company pages

Datasets

Frequently Asked Questions